Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy and radiation with or without tipifarnib in locally advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Pancreas
• Pancreatic Cancer

Drugs mentioned

• Tipifarnib (tipifarnib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer | Phase 2 | Status: COMPLETED